{
    "root": "cbc693d6-fa17-4710-b91f-22c4f5d74793",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Morphine Sulfate",
    "value": "20250513",
    "ingredients": [
        {
            "name": "MORPHINE SULFATE",
            "code": "X3P646A2J0"
        },
        {
            "name": "EDETATE DISODIUM",
            "code": "7FLD91C86K"
        },
        {
            "name": "CITRIC ACID MONOHYDRATE",
            "code": "2968PHW8QP"
        },
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I"
        }
    ],
    "indications": "Morphine Sulfate Injection, is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate.\n                  \n                     Limitations of Use\n                  \n                  \n                     Because of the risks of addiction, abuse, and misuse with opioids, which can occur at any dosage or duration [see Warnings and Precautions (5.1)], reserve Morphine Sulfate Injection for use in patients for whom alternative treatment options (e.g., nonopioid analgesics or opioid combination products):\n                  \n                  \n                     \n                        Have not been tolerated, or are not expected to be tolerated\n                     \n                     \n                        Have not provided adequate analgesia, or are not expected to provide adequate analgesia\n                     \n                  \n                  \n                     Morphine Sulfate Injection should not be used for an extended period of time unless the pain remains severe enough to require an opioid analgesic and for which alternative treatment options continue to be inadequate.",
    "contraindications": "Morphine Sulfate Injection should be prescribed only by healthcare professionals who are knowledgeable about the use of opioids and how to mitigate the associated risks. ( 2.1 ) Use the lowest effective dosage for the shortest duration of time consistent with individual patient treatment goals. Reserve titration to higher doses of Morphine Sulfate Injection for patients in whom lower doses are insufficiently effective and in whom the expected benefits of using a higher dose opioid clearly outweigh the substantial risks. ( 2.1 , 5 ) Many acute pain conditions (e.g., the pain that occurs with a number of surgical procedures or acute musculoskeletal injuries) require no more than a few days of an opioid analgesic. Clinical guidelines on opioid prescribing for some acute pain conditions are available. ( 2.1 ) Initiate the dosing regimen for each patient individually, taking into account the patient’s underlying cause and severity of pain, prior analgesic treatment and response, and risk factors for addiction, abuse, and misuse. ( 2.1 , 5.1 ) Respiratory depression can occur at any time during opioid therapy, especially when initiating and following dosage increases with Morphine Sulfate Injection. Consider this risk when selecting an initial dose and when making dose adjustments. ( 2.1 , 5.2 ) Direct Intravenous Injection: The usual starting dose in adults is 0.1 mg to 0.2 mg per kg every 4 hours as needed for pain management. ( 2.2 ) Do not abruptly discontinue Morphine Sulfate Injection in a physically dependent patient. ( 2.4 )",
    "warningsAndPrecautions": "Morphine Sulfate Injection, USP is supplied as a sterile solution in single-dose 1 mL prefilled syringes for intravenous administration as follows:  \n                  2 mg/mL packaged in 10s (NDC 0641-6191-10) \n                  4 mg/mL packaged in 10s (NDC 0641-6192-10) \n                  Store at 20°C to 25°C (68°F to 77°F) [See USP Controlled Room Temperature] until ready to use. PROTECT FROM LIGHT. \n                     DO NOT FREEZE. Contains no preservative or antioxidant. DISCARD ANY UNUSED PORTION. DO NOT HEAT-STERILIZE.",
    "adverseReactions": "Morphine Sulfate Injection is contraindicated in patients with:\n                  \n                     Significant respiratory depression [see WARNINGS AND PRECAUTIONS (5.2)]\n                     \n                     Acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see WARNINGS AND PRECAUTIONS (5.7)]\n                     \n                     Concurrent use of monoamine oxidase inhibitors (MAOIs) or use of MAOIs within the last 14 days [see WARNINGS AND PRECAUTIONS (5.8)]\n                     \n                     Known or suspected gastrointestinal obstruction, including paralytic ileus [see WARNINGS AND PRECAUTIONS (5.12)]\n                     \n                     Hypersensitivity to morphine (e.g., anaphylaxis) [see ADVERSE REACTIONS (6)]"
}